|
|
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
|
|
|
Transgenic non-human animals capable of producing heterologous antibodies
The design of a transgenic non-human animal that responds to foreign antigen stimulation with a heterologous antibody repertoire, requires that the heterologous ...
|
|
|
Transgenic non-human animals capable of producing heterologous antibodies
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
|
|
|
Transgenic non-human animals for producing heterologous antibodies
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
|
|
|
Nucleic acids encoding lymphoid CD30 antigen
We claim: 1. An isolated nucleic acid molecule comprising a polynucleotide having a sequence encoding the amino acid sequence of SEQ. ID. NO.: 2. 2. A recombinant vector ...
|
|
|
Feeding tray for multiwell test apparatus
This invention will be described herein with reference to the growing and use of cells on a membrane positioned and secured to the bottom of each of a multiplicity of ...
|
|
|
Neo-tryptophan
What is claimed is: 1. A method of making a neurotensin polypeptide containing neo-tryptophan, said method comprising: a) providing a neo-tryptophan derivative, and b) ...
|
|
|
Human immunodeficiency virus decoy
OF THE INVENTION The present invention has wide application to immunologic procedures and methods wherein antigenic material or other biologically active moieties are ...
|
|
|
Capsid forming and cystein modified chimaeric MS2-coat protein
We claim: 1. A modified coat protein capable of forming a capsid which comprises the coat protein of a bacteriophage selected from the group consisting of MS-2, R17 and ...
|
|
|
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
This invention relates to the discovery of an anti-idiotype antibody that is capable of recruiting a tumor-specific response against GD2. The antibody is designated 1A7....
|